India’s Shift to High-Value, Innovation-Led Pharma: Spotlight on GLP-1
India’s GLP-1 market opened up almost overnight. Semaglutide came off patent in March 2026, and multiple Indian manufacturers launched generics […]
BIOPHARMACEUTICAL-INNOVATION
India’s GLP-1 market opened up almost overnight. Semaglutide came off patent in March 2026, and multiple Indian manufacturers launched generics […]
